Chinese Drug Regulator Puts Sichuan Biokin Pharmaceutical's Naxopharynx Cancer Drug in Breakthrough Drugs List
Chinese Drug Regulator Puts Sichuan Biokin Pharmaceutical's Naxopharynx Cancer Drug in Breakthrough Drugs List
中國藥品監管機構將四川博康製藥的Naxopharynx抗癌藥物列入突破性藥物清單
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊